Show
Sort by
-
Mepolizumab reduces disease symptoms for patients with chronic rhinosinusitis with nasal polyps : data from the SYNAPSE study
(2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 147(2). p.AB126-AB126 -
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps : a systematic review for the EAACI guidelines
-
International consensus statement on allergy and rhinology : rhinosinusitis 2021
-
- Journal Article
- A1
- open access
Real-life assessment of chronic rhinosinusitis patients using mobile technology : the mySinusitisCoach project by EUFOREA
-
The GALEN rhinosinusitis cohort : chronic rhinosinusitis with nasal polyps affects health-related quality of life
-
- Journal Article
- A1
- open access
EUFOREA consensus on biologics for CRSwNP with or without asthma
-
- Journal Article
- A1
- open access
The Global Allergy and Asthma European Network (GALEN) rhinosinusitis cohort : a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps
-
EPOS2020 : development strategy and goals for the latest European Position Paper on Rhinosinusitis
-
- Journal Article
- A1
- open access
European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases : report of the European Union Parliament Summit (29 March 2017)
-
- Journal Article
- A1
- open access
Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers
-
- Conference Paper
- C3
- open access
The ‘GA^2LEN sinusitis cohort’ : an introduction
-
- Conference Paper
- C3
- open access
The 'GA2LEN Sinusitis Cohort' : an introduction
-
The GALEN sinusitis cohort : impact on quality of life in patients with chronic rhinosinusitis with nasal polyps (CRSwNP)
-
- Journal Article
- A2
- open access
Diagnostic tools in Rhinology EAACI position paper
-
Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis